BMEZ

BlackRock Health Sciences Trust II

NYSE: BMEZ · FINANCIAL SERVICES · ASSET MANAGEMENT

$17.29

-1.26% today

Updated 2026-11-12

Market cap

$1.10B

P/E ratio

5.18

P/S ratio

5.15x

EPS (TTM)

$3.39

Dividend yield

—

52W range

$13 – $18

Volume

0.2M

Market cap

$1.10B

P/E ratio

5.18

P/S ratio

5.15x

EPS (TTM)

$3.39

Dividend yield

—

52W range

$13 – $18

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

6.0

Quality

4.0

Profitability

6.7

Valuation

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →259 stocks currently score above 75

Price targets

Analyst target

$14.00

-19.03%

12-Month target

$14.00

-19.03%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Free cash flow $78.91M — positive

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$59.66M	$-25.97M	$8.19M	$24.07M	$24.46M
Net income	$59.12M	$-26.47M	$20.02M	$23.45M	$-22.49M
EPS	—	—	—	—	$3.39
Free cash flow	$-21.56M	$-874045.00	$32.02M	$65.52M	$78.91M
Profit margin	99.09%	101.93%	244.30%	97.44%	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-01-30	XIE, H ERIN	Buy	17,560	$15.21
2026-01-30	XIE, H ERIN	Sale	8,915	—
2026-01-30	XIE, H ERIN	Sale	8,862	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BMEZ	$1.10B	30	3.3	4.0	6.7	6.0	—	Avoid
BRK-A	$1.16T	74	7.3	7.5	5.0	8.5	—	Strong Buy
BRK-B	$1.16T	74	7.3	7.5	5.0	8.0	—	Strong Buy
JPM	$895.04B	73	7.3	8.0	6.3	3.0	—	Strong Buy
V	$773.00B	70	7.3	10.0	4.3	5.5	—	Strong Buy
MA	$555.82B	70	7.3	10.0	4.3	5.5	—	Strong Buy

Smart narrative

BlackRock Health Sciences Trust II trades at $17.29. representing a P/E of 5.18x trailing earnings. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is BlackRock Health Sciences Trust II's stock price?

BlackRock Health Sciences Trust II (BMEZ) trades at $17.29, on a P/E of 5.2x and a P/S of 5.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is BlackRock Health Sciences Trust II overvalued?

BlackRock Health Sciences Trust II carries a Smart Value Score of 30/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of BlackRock Health Sciences Trust II (BMEZ)?

The 12-month analyst consensus target is $14.00, about 19.0% below the current $17.29. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorFINANCIAL SERVICES

IndustryASSET MANAGEMENT

CountryUSA

ExchangeNYSE

CurrencyUSD

Quick metrics

P/S ratio5.15x

ROE5.66%

Beta—

50D MA$16.74

200D MA$15.31

Shares out0.06B

Float—

Short ratio—

Avg volume0.2M

Performance

1 week+0.50%

1 month+5.11%

3 months+15.88%

YTD+6.64%

1 year—

3 years—

5 years—

Compare

BMEZ vs BRK-A →BMEZ vs BRK-B →BMEZ vs JPM →Stock screener →